Empagliflozin trials for Obesity

All Empagliflozin trials · All Obesity trials

Phase breakdown

Recruiting trials studying Empagliflozin for Obesity

• A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
  NCT07331389 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
  NCT06745063 · Phase: Phase 2 · Ages: 30 Years to 60 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
  NCT06762314 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Empagliflozin for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.